A Phase I Study of Irinotecan Combined with BAY1895344 (ATR Inhibitor) in Advanced Solid Tumors: Results of ETCTN 10402 Dose Escalation.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined